Skin disorders in women with poor obstetric history: MTHFR polymorphisms and importance of preconceptional counseling

References

• Hoffer LJ. Homocysteine remethylation and trans-sulfuration. Metabolism. 2004;53(11):1480–1483. doi: 10.1016/j.metabol.2004.06.003.
   PubMed Web of Science ®Google Scholar
• Stover PJ. One-carbon metabolism–genome interactions in folate-associated pathologies. J Nutr. 2009;139(12):2402–2405. doi: 10.3945/jn.109.113670.
   PubMed Web of Science ®Google Scholar
• Recber T, Orgul G, Aydın E, et al. Metabolic infrastructure of pregnant women with methylenetetrahydrofolate reductase polymorphisms: a metabolomic analysis. Biomed Chromatogr. 2020;34(8):e4842.
   PubMed Web of Science ®Google Scholar
• Günebak Şahin T, Sayal B, Coşgun E, et al. Methylenetetrahydrofolate reductase enzyme mutations and relationship of homocysteine, vitamin B12 and folate blood levels. Gynecol Obstet Reprod Med. 2013;19:1–6.
   Google Scholar
• Castro R, Rivera I, Ravasco P, et al. 5,10-Methylenetetrahydrofolate reductase (MTHFR) 677C→T and 1298A→C mutations are associated with DNA hypomethylation. J Med Genet. 2004;41(6):454–458. doi: 10.1136/jmg.2003.017244.
   PubMed Web of Science ®Google Scholar
• Turgal M, Yazicioglu A, Ozyuncu O, et al. Impaired DNA methylation leading to heterotrisomy. J Obstet Gynaecol. 2013;33(8):904–905. doi: 10.3109/01443615.2013.838547.
   PubMedGoogle Scholar
• Locasale JW. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer. 2013;13(8):572–583. doi: 10.1038/nrc3557.
   PubMed Web of Science ®Google Scholar
• Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111–113. doi: 10.1038/ng0595-111.
   PubMed Web of Science ®Google Scholar
• Weisberg I, Tran P, Christensen B, et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64(3):169–172. doi: 10.1006/mgme.1998.2714.
   PubMed Web of Science ®Google Scholar
• Nurk E, Tell GS, Refsum H, et al. Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: the Hordaland homocysteine study. Am J Med. 2004;117(1):26–31. doi: 10.1016/j.amjmed.2004.01.019.
   PubMed Web of Science ®Google Scholar
• Turgal M, Gumruk F, Karaagaoglu E, et al. Methylenetetrahydrofolate reductase polymorphisms and pregnancy outcome. Geburtshilfe Frauenheilkd. 2018;78(9):871–878. doi: 10.1055/a-0664-8237.
   PubMed Web of Science ®Google Scholar
• Gurbuz RH, Atilla P, Orgul G, et al. Impaired placentation and early pregnancy loss in patients with MTHFR polymorphisms and type-1 diabetes mellitus. Fetal Pediatr Pathol. 2019;38(5):376–386. doi: 10.1080/15513815.2019.1600623.
   PubMed Web of Science ®Google Scholar
• Beksac MS, Tanacan A, Ozten G, et al. Low-dose low-molecular-weight heparin prophylaxis against obstetrical complications in pregnancies with metabolic and immunological disorder-associated placental inflammation. J Matern Neonatal Med. 2022;35(8):1546–1553. doi: 10.1080/14767058.2020.1760834.
   PubMed Web of Science ®Google Scholar
• Beksac K, Tanacan A, Cagan M, et al. Relationship of cholelithiasis and urolithiasis with methylenetetrahydrofolate reductase polymorphisms. J Invest Surg. 2021;34(10):1104–1107. doi: 10.1080/08941939.2020.1742402.
   PubMed Web of Science ®Google Scholar
• Tanacan A, Beksac MS. Spontaneous pregnancies in patients with at least one failed IVF cycle after the management of autoimmune disorders, hereditary thrombophilia, and methylation disorders. J Bras Reprod Assist. 2019;23:361–366.
   PubMed Web of Science ®Google Scholar
• Ozek MA, Karaagaoglu E, Orgul G, et al. Comparison of different types of twin pregnancies in terms of obstetric and perinatal outcomes: association of vanished twins with methylenetetrahydrofolate reductase (MTHFR) polymorphism(s). J Assist Reprod Genet. 2018;35(12):2149–2154. doi: 10.1007/s10815-018-1346-7.
   PubMed Web of Science ®Google Scholar
• Beksac MS, Beksac AT, Buyukeren M, et al. Are congenital urinary tract abnormalities linked to maternal methylenetetrahydrofolate reductase polymorphisms in fetuses of intentionally terminated pregnancies with oligo- or anhydramnios ? Fetal Pediatr Pathol. 2018;37(3):177–183. doi: 10.1080/15513815.2018.1461283.
   PubMed Web of Science ®Google Scholar
• Beksac MS, Balci S, Guvendag Guven ES, et al. Complex conotruncal cardiac anomalies consecutively in three siblings from a consanguineous family possibly associated with maternal hyperhomocysteinemia. Arch Gynecol Obstet. 2007;276(5):547–549. doi: 10.1007/s00404-007-0367-8.
   PubMedGoogle Scholar
• Fowler B. Homocysteine: overview of biochemistry, molecular biology, and role in disease processes. Semin Vasc Med. 2005;5(2):77–86. doi: 10.1055/s-2005-872394.
   PubMedGoogle Scholar
• Thompson M. An uncomfortable problem of sore and cracked lips (APAFT). Aust Pharm. 2014;3:60–63.
   Google Scholar
• Karabacak E, Aydin E, Ozcan O, et al. Methylenetetrahydrofolate reductase (MTHFR) 677C > T gene polymorphism as a possible factor for reducing clinical severity of psoriasis. Int J Clin Exp Med. 2014;7:697–702.
   PubMed Web of Science ®Google Scholar
• Han J, Colditz GA, Hunter DJ. Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis. 2007;28(2):390–397. doi: 10.1093/carcin/bgl156.
   PubMed Web of Science ®Google Scholar
• Laing ME, Cummins R, O’Grady A, et al. Aberrant DNA methylation associated with MTHFR C677T genetic polymorphism in cutaneous squamous cell carcinoma in renal transplant patients. Br J Dermatol. 2010;163(2):345–352. doi: 10.1111/j.1365-2133.2010.09774.x.
   PubMed Web of Science ®Google Scholar
• Perna AF, Ingrosso D, De Santo NG. MTHFR C677T polymorphism and skin color: the white man’s blackness. Kidney Int. 2004;65(6):2444. doi: 10.1111/j.1523-1755.2004.665_3.x.
   PubMed Web of Science ®Google Scholar
• Zhang HZ, Wu JH, Huang Q, et al. Associations of methylenetetrahydrofolate reductase gene (MTHFR) rs1801131 and rs1801133 polymorphisms with susceptibility to vitiligo: a meta-analysis. J Cosmet Dermatol. 2021;20(7):2359–2368. doi: 10.1111/jocd.13857.
   PubMed Web of Science ®Google Scholar
• Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost. 2005;3(2):292–299. doi: 10.1111/j.1538-7836.2005.01141.x.
   PubMed Web of Science ®Google Scholar
• New D, Eaton P, Knable A, et al. The use of B vitamins for cutaneous ulcerations mimicking pyoderma gangrenosum in patients with MTHFR polymorphism. Arch Dermatol. 2011;147(4):450–453. doi: 10.1001/archdermatol.2011.77.
   PubMed Web of Science ®Google Scholar
• Ozarda Y, Sucu DK, Hizli B, et al. Rate of T alleles and TT genotype at MTHFR 677C->T locus or C alleles and CC genotype at MTHFR 1298A->C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference intervals. Cell Biochem Funct. 2009;27(8):568–577. doi: 10.1002/cbf.1610.
   PubMed Web of Science ®Google Scholar
• Sazci A, Ergul E, Kaya G, et al. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell Biochem Funct. 2005;23(1):51–54. doi: 10.1002/cbf.1132.
   PubMed Web of Science ®Google Scholar
• Gumruk F, Orgul G, Dogan OA, et al. The prevalence of homozygous MTHFR polymorphism(s) in a Turkish university hospital population that necessitated MTHFR polymorphism investigation. Electron J Gen Med. 2018;15(4):em57. doi: 10.29333/ejgm/89674.
   Google Scholar
• Kalkan G, Yigit S, Karakuş N, et al. Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population. Gene. 2013;530(1):109–112. doi: 10.1016/j.gene.2013.08.016.
   PubMed Web of Science ®Google Scholar
• Tanacan E, Tanacan A, Fadiloglu E, et al. Psoriasis and pregnancy: retrospective evaluation of 47 pregnancies in a tertiary center. Gynecol Obstet Reprod Med. 2019;25(3):128–132. doi: 10.21613/GORM.2018.850.
   Google Scholar
• Wang WM, Jin HZ. Homocysteine: a potential common route for cardiovascular risk and DNA methylation in psoriasis. Chin Med J. 2017;130(16):1980–1986. doi: 10.4103/0366-6999.211895.
   PubMed Web of Science ®Google Scholar
• Leal JM, de Souza GH, Marsillac PFD, et al. Skin manifestations associated with systemic diseases – part II. An Bras Dermatol. 2021;96(6):672–687. doi: 10.1016/j.abd.2021.06.003.
   PubMedGoogle Scholar
• Vasku V, Bienertova-Vasku J, Necas M, et al. MTHFR (methylenetetrahydrofolate reductase) C677T polymorphism and psoriasis. Clin Exp Med. 2009;9(4):327–331. doi: 10.1007/s10238-009-0054-0.
   PubMed Web of Science ®Google Scholar
• Vanizor Kural B, Orem A, Cimşit G, et al. Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. Clin Chim Acta. 2003;332(1-2):23–30. doi: 10.1016/s0009-8981(03)00082-2.
   PubMed Web of Science ®Google Scholar
• Beksac B, Donmez HG, Cagan M, et al. Acrochordons and autoimmunity: significance of preconceptional counseling. Hum Antibodies. 2020;28(4):335–339. doi: 10.3233/HAB-200426.
   PubMedGoogle Scholar
• Sari R, Akman A, Alpsoy E, et al. The metabolic profile in patients with skin tags. Clin Exp Med. 2010;10(3):193–197. doi: 10.1007/s10238-009-0086-5.
   PubMed Web of Science ®Google Scholar